EUCTR2004-000592-33-IT
Active, not recruiting
Not Applicable
Prospective study of the incidence and outcome of Veno-occlusive disease (VOD)with the prophylactic use of Defibrotide (DF, Gentium, Italy) in pediatric stem cell transplantation
GENTIUM0 sites360 target enrollmentMarch 8, 2007
ConditionsPrevention of hepatic veno-occlusive disease in pediatric patients at high risk of VODMedDRA version: 14.1Level: PTClassification code 10047216Term: Venoocclusive liver diseaseSystem Organ Class: 10019805 - Hepatobiliary disordersTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Prevention of hepatic veno-occlusive disease in pediatric patients at high risk of VOD
- Sponsor
- GENTIUM
- Enrollment
- 360
- Status
- Active, not recruiting
- Last Updated
- 13 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 0
- •F.1\.2 Adults (18\-64 years) no
- •F.1\.2\.1 Number of subjects for this age range
- •F.1\.3 Elderly (\>\=65 years) no
- •F.1\.3\.1 Number of subjects for this age range
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Prospective Study of the Incidence and Outcome of Venoocclusive Disease (VOD) with the Prophylactic Use of Defibrotide (DF, Gentium, Italy) in Pediatric Stem Cell Transplantation - VOD-DF StudyHepatic veno-occlusive disease following hematopoietic stem cell transplantationEUCTR2004-000592-33-IEGentium S.p.A290
Active, not recruiting
Phase 1
Prospective Study of the Incidence and Outcome of Venoocclusive Disease (VOD) with the Prophylactic Use of Defibrotide (DF, Gentium, Italy) in Pediatric Stem Cell Transplantation - VOD-DF StudyHepatic veno-occlusive disease following hematopoietic stem cell transplantationMedDRA version: 9.1 Level: LLT Classification code 10047217 Term: Venoocclusive syndrome of the liverMedDRA version: 9.1 Level: LLT Classification code 10047207 Term: Veno-occlusive liver damageEUCTR2004-000592-33-GBGentium S.p.A270
Active, not recruiting
Not Applicable
Prospective Study of the Incidence and Outcome of Venoocclusive Disease (VOD) with the Prophylactic Use of Defibrotide (DF, Gentium, Italy) in Pediatric Stem Cell Transplantation - VOD-DF StudyHepatic veno-occlusive disease following hematopoietic stem cell transplantationMedDRA version: 9.1Level: LLTClassification code 10047217Term: Venoocclusive syndrome of the liverMedDRA version: 9.1Level: LLTClassification code 10047207Term: Veno-occlusive liver damageEUCTR2004-000592-33-SEGentium S.p.A270
Active, not recruiting
Not Applicable
Prospective Study of the Incidence and Outcome of Venoocclusive Disease (VOD) with the Prophylactic Use of Defibrotide (DF, Gentium, Italy) in Pediatric Stem Cell Transplantation - VOD-DF StudyHepatic veno-occlusive disease following hematopoietic stem cell transplantationMedDRA version: 9.1Level: LLTClassification code 10047217Term: Venoocclusive syndrome of the liverMedDRA version: 9.1Level: LLTClassification code 10047207Term: Veno-occlusive liver damageEUCTR2004-000592-33-CZGentium S.p.A270
Completed
Not Applicable
Exploratory prospective study of the incidence of cholecystitis after endoscopic biliary drainage using a novel partially covered self-expandable metallic stent for unresectable malignant distal biliary obstructiopatients with unresectable malignant distal biliary obstructionJPRN-UMIN000051182Kitasato University School of Medicine Department of Gastroenterology20